About US
Contact us
-
Celltrion plots $453M South Korean expansion to aid ambitious biosimilar pipeline push: reportSouth Korea's Celltrion has made its name recently with biosimilar copies of big-name blockbusters, and it has plans to add even more in the coming years. To get there, Celltrion is betting big on an2020/11/17
-
NICE's thumbs-up on Lilly's migraine med Emgality leaves rivals from Novartis and Teva in the dustEngland's drug cost watchdogs have not been gentle on companies marketing hot but expensive new CGRP inhibitors to treat migraine headaches. But they just made an exception for one of those companies2020/11/16
-
Airlines rally cold-chain supplies to ship Pfizer, Moderna's frigid COVID-19 shotsPositive data on Pfizer and Moderna's mRNA vaccine candidates havebeen tempered in recent weeks by concerns over shipping hurdles for the shots, both of which require stringent temperature controlto2020/11/16
-
Despite impressive data, FDA's coronavirus vaccine reviews will take weeks, not days, official saysAs leading COVID-19 vaccinespost positive phase 3 data and nearFDA submissions, the agency official in charge of reviewingvaccinesis emphasizing transparency andpatienceduringthehigh-stakes process.2020/11/13
-
CureVac, armed with COVID-19 vaccine deal, plots 'pandemic-scale' Euro manufacturing expansionAs Pfizer and Moderna dominate headlineswith positive interim readoutsfor their COVID-19 vaccine candidates, othermRNA players are taking note. Germany's CureVac, hot on the heels of an EU supplydeal2020/11/13
-
Cambrex looks to fill 'onshore' API manufacturing demand with $50M expansion in IowaWith the COVID-19 pandemic nearing its second year in the U.S., lawmakers have bangedthe drum on boosting "onshore" production of key pharmaceuticals and ingredients to ensure supply-side security. N2020/11/6
-
Lilly partners with Samsung to boost COVID-19 antibody manufacturing amid supply concernsA week after Eli Lilly won an FDA emergency authorization for its COVID-19 antibody, concerns over limited supplies are already popping up, and the company is bringing in an experienced manufacturing2020/11/6
-
Alkermes flops FDA's 'remote review' at manufacturing site for schizophrenia, bipolar disorder drugThe COVID-19 pandemic has changed the way the pharmaceutical industry works, crucially in how regulators inspect key manufacturing sites. To skirt around lockdowns, the FDA has started conducting "re2020/11/5
-
Buffett's Berkshire bets big on AbbVie, Bristol Myers, Merck, Pfizer as COVID-19 drives healthcare investmentAs the COVID-19 pandemic fuels a global interest in healthcare, many deep-pocketed investors havediverted their money to the sector. Billionaire Warren Buffett is among those who have now doubled dow2020/11/4
-
CureVac, EU ink supply deal for up to 405M doses of mRNA coronavirus shot: ReutersWith mRNA-based coronavirus vaccines from Pfizer and Moderna showing promise in late-stagestudies, another companyworking on a midstage mRNA candidatehas inked a large supply deal with the EU. CureVa2020/11/2